These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 28593402
1. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas. Byrne S, Connor S, Lascelles K, Siddiqui A, Hargrave D, Ferner RE. J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402 [Abstract] [Full Text] [Related]
2. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Falzon K, Drimtzias E, Picton S, Simmons I. Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527 [Abstract] [Full Text] [Related]
3. Intracranial gliomas in neurofibromatosis type 1. Listernick R, Charrow J, Gutmann DH. Am J Med Genet; 1999 Mar 26; 89(1):38-44. PubMed ID: 10469435 [Abstract] [Full Text] [Related]
4. Long-term outcome in children with gliomas of the anterior visual pathway. Tow SL, Chandela S, Miller NR, Avellino AM. Pediatr Neurol; 2003 Apr 26; 28(4):262-70. PubMed ID: 12849878 [Abstract] [Full Text] [Related]
5. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Guillamo JS, Créange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P, Réseau NF France. Brain; 2003 Jan 26; 126(Pt 1):152-60. PubMed ID: 12477702 [Abstract] [Full Text] [Related]
6. Special issues in the management of gliomas in children with neurofibromatosis 1. Pollack IF, Mulvihill JJ. J Neurooncol; 1996 Jan 26; 28(2-3):257-68. PubMed ID: 8832467 [Abstract] [Full Text] [Related]
13. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference. Packer RJ, Iavarone A, Jones DTW, Blakeley JO, Bouffet E, Fisher MJ, Hwang E, Hawkins C, Kilburn L, MacDonald T, Pfister SM, Rood B, Rodriguez FJ, Tabori U, Ramaswamy V, Zhu Y, Fangusaro J, Johnston SA, Gutmann DH. Neuro Oncol; 2020 Jun 09; 22(6):773-784. PubMed ID: 32055852 [Abstract] [Full Text] [Related]
15. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group. Ater JL, Xia C, Mazewski CM, Booth TN, Freyer DR, Packer RJ, Sposto R, Vezina G, Pollack IF. Cancer; 2016 Jun 15; 122(12):1928-36. PubMed ID: 27061921 [Abstract] [Full Text] [Related]
16. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Shamji MF, Benoit BG. Neurosurg Focus; 2007 Jun 15; 23(5):E3. PubMed ID: 18004965 [Abstract] [Full Text] [Related]